Earnings Alerts

Givaudan (GIVN) Earnings Review: 1Q Fragrance & Beauty Sales Surpass Estimates with Strong Growth

  • Givaudan’s first-quarter Fragrance & Beauty sales outperformed estimates.
  • Fragrance & Beauty sales reached CHF900 million, surpassing the anticipated CHF849.9 million.
  • The company’s like-for-like sales for Fragrance & Beauty rose by 16.3%, which was significantly higher than the expected rise of 8.46%.
  • Investment ratings for Givaudan show 6 buys, 14 holds, and 6 sells.

A look at Givaudan Smart Scores

FactorScoreMagnitude
Value2
Dividend3
Growth4
Resilience2
Momentum5
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Givaudan SA shows a promising long-term outlook. With a high Momentum score of 5, the company is experiencing strong positive price trends in the market. This indicates good potential for future growth. Additionally, Givaudan scores well in Growth with a score of 4, reflecting the company’s potential for expansion and development in the future. These scores suggest that Givaudan is positioned well for sustained growth and success in the long run.

Givaudan SA, a leading manufacturer and marketer of fragrances and flavors globally, has demonstrated its resilience within the market, as indicated by its Resilience score of 2. While the Value score is rated at 2, suggesting areas for improvement in terms of the company’s valuation, a Dividend score of 3 signifies a moderate level of dividend payout. Overall, Givaudan’s scores portray a favorable outlook for the company’s future growth and performance amidst its operations worldwide.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars